OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Partial inhibition of mitochondrial complex I ameliorates Alzheimer’s disease pathology and cognition in APP/PS1 female mice
Andrea Stojakovic, Sergey Trushin, Anthony Sheu, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Generation of Reactive Oxygen Species by Mitochondria
Pablo Hernansanz‐Agustín, José Antonio Enrı́quez
Antioxidants (2021) Vol. 10, Iss. 3, pp. 415-415
Open Access | Times Cited: 272

Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments
Muneeb U. Rehman, Nouroz Sehar, Nawab John Dar, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104961-104961
Closed Access | Times Cited: 83

Axonal energy metabolism, and the effects in aging and neurodegenerative diseases
Sen Yang, Jung Hyun Park, Hui‐Chen Lu
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 49

Mitochondrial disorders leading to Alzheimer’s disease—perspectives of diagnosis and treatment
Magdalena Pszczołowska, Kamil Walczak, Weronika Miśków, et al.
GeroScience (2024) Vol. 46, Iss. 3, pp. 2977-2988
Open Access | Times Cited: 17

Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery
Francesca R. Buccellato, Marianna D’Anca, Chiara Fenoglio, et al.
Antioxidants (2021) Vol. 10, Iss. 9, pp. 1353-1353
Open Access | Times Cited: 98

Mitochondrial complex I as a therapeutic target for Alzheimer's disease
Eugenia Trushina, Sergey Trushin, Md Fayad Hasan
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 483-495
Open Access | Times Cited: 76

Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease
Steven N. Austad, Scott W. Ballinger, Thomas W. Buford, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 511-531
Open Access | Times Cited: 57

Autophagy promotes cell survival by maintaining NAD levels
Tetsushi Kataura, Lucia Sedlackova, Elsje G. Otten, et al.
Developmental Cell (2022) Vol. 57, Iss. 22, pp. 2584-2598.e11
Open Access | Times Cited: 52

A Comprehensive Approach to Sample Preparation for Electron Microscopy and the Assessment of Mitochondrial Morphology in Tissue and Cultured Cells
Antentor Hinton, Prasanna Katti, Trace Christensen, et al.
Advanced Biology (2023) Vol. 7, Iss. 10
Open Access | Times Cited: 36

The Role of PGC-1α-Mediated Mitochondrial Biogenesis in Neurons
Mengjie Chen, Ru-Yu Yan, Jian-Sheng Luo, et al.
Neurochemical Research (2023) Vol. 48, Iss. 9, pp. 2595-2606
Closed Access | Times Cited: 27

Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction—the trigger for PANoptosis in neurons
Xiangyuan Meng, Qi Song, Zinan Liu, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 12

Interactions between amyloid, amyloid precursor protein, and mitochondria
Heather Wilkins
Biochemical Society Transactions (2023) Vol. 51, Iss. 1, pp. 173-182
Open Access | Times Cited: 21

Oleuropein confers neuroprotection against rotenone-induced model of Parkinson’s disease via BDNF/CREB/Akt pathway
Richa Singh, Walia Zahra, Saumitra Sen Singh, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 20

Characterization of Mitochondrial DNA Methylation of Alzheimer’s Disease in Plasma Cell-Free DNA
Binrong Ding, Xue-wei Zhang, Zhengqing Wan, et al.
Diagnostics (2023) Vol. 13, Iss. 14, pp. 2351-2351
Open Access | Times Cited: 19

Proteostasis disruption and senescence in Alzheimer’s disease pathways to neurodegeneration
Riya Thapa, Asif Ahmad Bhat, Moyad Shahwan, et al.
Brain Research (2024) Vol. 1845, pp. 149202-149202
Closed Access | Times Cited: 8

Alcohol-Induced Neuroinflammatory Response and Mitochondrial Dysfunction on Aging and Alzheimer’s Disease
Brandon Emanuel León, Shinwoo Kang, Gabriela Franca-Solomon, et al.
Frontiers in Behavioral Neuroscience (2022) Vol. 15
Open Access | Times Cited: 23

Transcriptomic and epigenomic landscapes of Alzheimer's disease evidence mitochondrial-related pathways
Alejandro Marmolejo-Garza, Tiago Medeiros-Furquim, Ramya Rao, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2022) Vol. 1869, Iss. 10, pp. 119326-119326
Open Access | Times Cited: 20

Partial Inhibition of Complex I Restores Mitochondrial Morphology and Mitochondria-ER Communication in Hippocampus of APP/PS1 Mice
Jessica Panes, Thi Kim Oanh Nguyen, Huanyao Gao, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1111-1111
Open Access | Times Cited: 11

Diastolic dysfunction in Alzheimer’s disease model mice is associated with Aβ-amyloid aggregate formation and mitochondrial dysfunction
Richa Aishwarya, Chowdhury S. Abdullah, Naznin Sultana Remex, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4

Therapeutic assessment of a novel mitochondrial complex I inhibitor in in vitro and in vivo models of Alzheimer′s disease
Sergey Trushin, Thi Kim Oanh Nguyen, Andrea Stojakovic, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Brain transcriptomic profiling reveals common alterations across neurodegenerative and psychiatric disorders
Iman Sadeghi, Juan Domingo Gispert, Emilio Palumbo, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 4549-4561
Open Access | Times Cited: 16

Page 1 - Next Page

Scroll to top